NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Clinical Laserthermia Systems AB (publ) (ST: CLS-B)

 
CLS-B Technical Analysis
4
As on 22nd Nov 2024 CLS-B STOCK Price closed @ 4.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.10 & Strong Buy for SHORT-TERM with Stoploss of 0.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CLS-BSTOCK Price

Open 3.82 Change Price %
High 4.50 1 Day 0.72 19.05
Low 3.70 1 Week 0.42 10.29
Close 4.50 1 Month -0.50 -10.00
Volume 68128 1 Year 4.32 2400.00
52 Week High 23.44 | 52 Week Low 0.08
 
ST Sweden Most Active Stocks
TANGI 0.00 %
FING-B 0.08 0.00%
SBB-B 4.00 1.78%
LUNE 21.97 6.65%
SNM 0.88 2.33%
DIABIO 0.03 0.00%
WYLD 0.02 0.00%
NIBE-B 45.75 1.87%
HDW-B 0.00 %
EURA 0.01 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
STAR-A 0.26 30.00%
LCLEAN 3.20 25.49%
QIIWI 3.10 22.05%
APTR 0.23 21.05%
FLUI 0.06 20.00%
CLS-B 4.50 19.05%
SIVE 2.24 16.06%
SIVE 2.24 16.06%
 
ST Sweden Top Losers Stocks
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
LOHILO 1.58 -18.56%
ADDV-A 9.82 -18.17%
PHARM 0.56 -16.42%
PHARM 0.56 -16.42%
ONCOZ 3.50 -13.37%
SCOL 0.07 -12.50%
 
 
CLS-B
Daily Charts
CLS-B
Intraday Charts
Whats New @
Bazaartrend
CLS-B
Free Analysis
 
CLS-B Important Levels Intraday
RESISTANCE6.04
RESISTANCE5.55
RESISTANCE5.24
RESISTANCE4.94
SUPPORT4.06
SUPPORT3.76
SUPPORT3.45
SUPPORT2.96
 
CLS-B Forecast November 2024
4th UP Forecast4.62
3rd UP Forecast4.58
2nd UP Forecast4.56
1st UP Forecast4.53
1st DOWN Forecast4.47
2nd DOWN Forecast4.44
3rd DOWN Forecast4.42
4th DOWN Forecast4.38
 
CLS-B Weekly Forecast
4th UP Forecast4.62
3rd UP Forecast4.58
2nd UP Forecast4.56
1st UP Forecast4.53
1st DOWN Forecast4.47
2nd DOWN Forecast4.44
3rd DOWN Forecast4.42
4th DOWN Forecast4.38
 
CLS-B Forecast2024
4th UP Forecast51.36
3rd UP Forecast36.33
2nd UP Forecast27.04
1st UP Forecast17.75
1st DOWN Forecast-8.75
2nd DOWN Forecast-18.04
3rd DOWN Forecast-27.33
4th DOWN Forecast-42.36
 
 
CLS-B Other Details
Segment EQ
Market Capital 305537600.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
CLS-B Address
CLS-B
 
CLS-B Latest News
 
Your Comments and Response on Clinical Laserthermia Systems AB (publ)
 
CLS-B Business Profile
Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service